AerWave Medical, a leader in ultrasound-based interventional pulmonary solutions, today announced the successful completion of its first-in-human (FIH) feasibility study of its disease-modifying ...

Many people’s symptoms worsen during the winter period. “We call this an exacerbation or a flare up, when you get ...

Winter season can trigger symptoms of atopic dermatitis by causing the skin to become dry and itchy in the cold weather. It ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

For healthy individuals, HMPV causes mild illness and resolves on its own. However, the vulnerable population must take ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

The recent surge in Human Metapneumovirus (HMPV) cases in China has triggered global attention, prompting the Indian health ...

Broncho-Vaxom is under clinical development by OM Pharma and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I drugs for Allergic Asthma have a 78% phase transition success ...

Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives.

Researchers at the University of Pittsburgh have developed a new nasal swab test that identifies specific asthma subtypes in ...

Hundreds of thousands of patients will be able to get directly referred and booked in for tests, checks and scans by their GP for a range of conditions as part of a radical new plan set to be launched ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...